We are live on ! Find out more
SA

Strategic Advocates Portfolio holdings

AUM $22.6M
1-Year Est. Return 26.98%
This Fund
S&P 500
This Quarter Est. Return
+7.3%
1 Year Est. Return
+26.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$260M
AUM Growth
+$24.4M
Cap. Flow
+$10.5M
Cap. Flow %
4.03%
Top 10 Hldgs %
55.39%
Holding
182
New
32
Increased
41
Reduced
47
Closed
56

Sector Composition

Rank Sector Weight
1 Technology 14.21%
2 Financials 3.93%
3 Consumer Discretionary 3.65%
4 Healthcare 2.98%
5 Communication Services 2.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BX icon
101
Blackstone
BX
$112B
$284K 0.11%
+2,159
New +$270K
CLH icon
102
Clean Harbors
CLH
$16.4B
$278K 0.11%
1,380
UNP icon
103
Union Pacific
UNP
$174B
$277K 0.11%
1,128
-2
-0.2% -$492
CME icon
104
CME Group
CME
$95.3B
$271K 0.1%
+1,259
New +$264K
QYLD icon
105
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.27B
$263K 0.1%
14,685
-8,771
-37% -$155K
VEA icon
106
Vanguard FTSE Developed Markets ETF
VEA
$236B
$256K 0.1%
5,102
-5,453
-52% -$263K
GNR icon
107
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.94B
$250K 0.1%
4,316
-4,029
-48% -$219K
MUC icon
108
BlackRock MuniHoldings California Quality Fund
MUC
$1.01B
$249K 0.1%
22,621
ILCG icon
109
iShares Morningstar Growth ETF
ILCG
$3.26B
$246K 0.09%
3,265
ANET icon
110
Arista Networks
ANET
$242B
$246K 0.09%
3,392
-624
-16% -$42.1K
DUOL icon
111
Duolingo
DUOL
$6.28B
$234K 0.09%
1,061
+177
+20% +$36.1K
DEM icon
112
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
$233K 0.09%
5,575
-4,363
-44% -$178K
MRK icon
113
Merck
MRK
$323B
$230K 0.09%
+1,743
New +$215K
IMCG icon
114
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.12B
$229K 0.09%
3,237
NOW icon
115
ServiceNow
NOW
$131B
$227K 0.09%
1,490
-1,765
-54% -$267K
CPRX
116
DELISTED
Catalyst Pharmaceutical
CPRX
$212K 0.08%
+13,278
New +$200K
XOM icon
117
ExxonMobil
XOM
$663B
$211K 0.08%
1,817
-742
-29% -$77.6K
ZION icon
118
Zions Bancorporation
ZION
$10.3B
$211K 0.08%
4,853
-283
-6% -$11.7K
IHI icon
119
iShares US Medical Devices ETF
IHI
$3.43B
$210K 0.08%
+3,580
New +$202K
SPY icon
120
State Street SPDR S&P 500 ETF Trust
SPY
$809B
$209K 0.08%
+400
New +$199K
PGX icon
121
Invesco Preferred ETF
PGX
$3.76B
$204K 0.08%
17,180
-13,475
-44% -$159K
FSCO
122
FS Credit Opportunities Corp
FSCO
$1.01B
$196K 0.08%
33,117
-3,738
-10% -$21.5K
MGNI icon
123
Magnite
MGNI
$3.48B
$190K 0.07%
+17,641
New +$176K
T icon
124
AT&T
T
$165B
$180K 0.07%
10,252
-5,376
-34% -$91.8K
ET icon
125
Energy Transfer Partners
ET
$70.9B
$168K 0.06%
10,662
-1,714
-14% -$25K

Similar funds

Strategic Advocates's Q1 2024 Portfolio in Review

As of Q1 2024, Strategic Advocates held 182 positions worth $260M, up 10% from $235M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Strategic Advocates deployed $10.5M of net new capital in Q1 2024, opening 32 new positions and adding to 41 existing holdings. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 78,824 shares worth $4.04M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Schwab US Large-Cap Growth ETF, an estimated $16M trimmed.

  • Strategic Advocates's largest Q1 2024 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 78,824 shares worth $4.04M.
  • Strategic Advocates added most to State Street SPDR S&P Kensho New Economies Composite ETF in Q1 2024, an estimated $18.6M increase.
  • Strategic Advocates's biggest Q1 2024 reduction was Schwab US Large-Cap Growth ETF, cutting an estimated $16M.
  • Strategic Advocates fully exited State Street SPDR Portfolio Long Term Treasury ETF in Q1 2024, selling an estimated $4.74M.
  • Strategic Advocates's ten largest holdings make up 55% of its $260M portfolio in Q1 2024.
  • Strategic Advocates opened 32 new positions and closed 56 in Q1 2024.
  • Strategic Advocates's portfolio value rose 10% quarter-over-quarter to $260M.

Based on Strategic Advocates's 13F filing for Q1 2024, filed 3 Apr 2024.